This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
- Field
- Drug Design Development and Therapy, July 2010, Taylor & Francis
- DOI: 10.2147/dddt.s7667
